Literature DB >> 26154577

Comparison of Survival Outcomes Between Right Posterior Sectionectomy and Right Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Liver: A Single-Centre Experience.

Vincent S K Yip1,2, Ronnie T P Poon1, Kenneth S H Chok1, Albert C Y Chan1, Wing Chiu Dai1, Simon H Y Tsang1, See Ching Chan1, Chung Mau Lo1, Tan To Cheung3.   

Abstract

BACKGROUND: Right hepatectomy (RH) instead of right posterior sectionectomy (RPS) is commonly performed for hepatocellular carcinoma (HCC) in cirrhotic livers located lateral to the right hepatic vein in order to ensure adequate resection margin. This potentially increased the risk of postoperative liver failure. This study aims to compare survival outcomes and surgical morbidities between RH and RPS.
METHODS: All patients between 2003 and 2013 with resection for solitary HCC in cirrhotic livers at segment 6/7 were reviewed. Baseline demographics, liver function, perioperative outcomes, and overall (OS) and disease-free survival (DFS) were compared between RH and RPS.
RESULTS: Eighty-one patients were included in this study. Thirty-two patients had RH and forty-nine with RPS were selected as controls. Majority of the HCC patients (91.4 %) suffered from chronic hepatitis B. There was no significant difference in age, gender and Child-Pugh grade between the two groups. The median tumour size of RH group was 6 vs. 4 cm in the RPS group (p < 0.0001). Both groups had no statistical difference in resection margin and their associated morbidities. The 5-year OS for RH and RPS was 76 and 83.8 %, respectively (p = 0.766), whereas their corresponding DFS was 52.6 and 52.2 % (p = 0.859). Despite the discrepancy of tumour size among the two groups, there was no statistical difference in subgroup analysis based on their corresponding stage of disease.
CONCLUSION: RPS can achieve similar OS and DFS as RH for HCC, and should be considered as the treatment of choice in order to optimise the postoperative remnant parenchymal liver functions.

Entities:  

Mesh:

Year:  2015        PMID: 26154577     DOI: 10.1007/s00268-015-3146-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

1.  Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy.

Authors:  H Lau; K Man; S T Fan; W C Yu; C M Lo; J Wong
Journal:  Br J Surg       Date:  1997-09       Impact factor: 6.939

2.  Anatomical versus nonanatomical resection in patients with hepatocellular carcinoma located in the left lateral segment.

Authors:  Kazunari Sasaki; Masamichi Matsuda; Yu Ohkura; Masaji Hashimoto; Goro Watanabe
Journal:  Am Surg       Date:  2013-11       Impact factor: 0.688

3.  Anatomic resection of liver segments 6-8 for hepatocellular carcinoma.

Authors:  Chang-Ku Jia; Jie Weng; You-Ke Chen; Yu Fu
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

4.  Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Authors:  J M Llovet; J Fuster; J Bruix
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

Review 5.  Hepatobiliary malignancies: lessons from Asia.

Authors:  Tiffany C L Wong; Ronnie T P Poon
Journal:  Dig Dis       Date:  2013-06-17       Impact factor: 2.404

6.  Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma.

Authors:  Hyunkyung Yoo; Jin Hyoung Kim; Gi-Young Ko; Kyoung Won Kim; Dong Il Gwon; Sung-Gyu Lee; Shin Hwang
Journal:  Ann Surg Oncol       Date:  2010-11-11       Impact factor: 5.344

7.  11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.

Authors:  Tan To Cheung; Chi Lai Ho; Chung Mau Lo; Sirong Chen; See Ching Chan; Kenneth S H Chok; James Y Fung; Albert Chi Yan Chan; William Sharr; Thomas Yau; Ronnie T P Poon; Sheung Tat Fan
Journal:  J Nucl Med       Date:  2013-01-15       Impact factor: 10.057

8.  Comparison of two methods of future liver remnant volume measurement.

Authors:  Yun Shin Chun; Dario Ribero; Eddie K Abdalla; David C Madoff; Melinda M Mortenson; Steven H Wei; Jean-Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2007-10-09       Impact factor: 3.452

9.  Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria.

Authors:  Jingxiang Shi; Quan Sun; Yijun Wang; Xiang Jing; Jianmin Ding; Qiang Yuan; Chaoyi Ren; Shigang Shan; Yandong Wang; Zhi Du
Journal:  J Gastroenterol Hepatol       Date:  2014       Impact factor: 4.029

10.  Propensity score analysis demonstrated the prognostic advantage of anatomical liver resection in hepatocellular carcinoma.

Authors:  Masayuki Ishii; Toru Mizuguchi; Masaki Kawamoto; Makoto Meguro; Shigenori Ota; Toshihiko Nishidate; Kenji Okita; Yasutohsi Kimura; Thomas T Hui; Koichi Hirata
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

View more
  3 in total

Review 1.  Treatment Options for Early-Stage Hepatocellular Carcinoma.

Authors:  Nora E Tabori; Gajan Sivananthan
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

2.  Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosis.

Authors:  Xiao-Dong Gai; Wei-Feng Wu
Journal:  Exp Ther Med       Date:  2017-08-18       Impact factor: 2.447

Review 3.  Liver Resection and Surgical Strategies for Management of Primary Liver Cancer.

Authors:  Sonia T Orcutt; Daniel A Anaya
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.